tiprankstipranks
Ampio Pharmaceuticals (AMPE)
OTHER OTC:AMPE
US Market

Ampio Pharmaceuticals (AMPE) Ownership - Who Owns Ampio Pharmaceuticals?

511 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 13, 2023
Kevin Buchi
Director
Bought$6120
Jun 09, 2023
Kevin Buchi
Director
Bought$7250
May 26, 2023
Michael Martino
Ceo,director
Bought$21529
May 17, 2023
Kevin Buchi
Director
Bought$8784

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,624,882Insider231.19%750,716
575,000Insider50.64%164,450
319,549Insider28.15%91,391
203,500Insider17.92%58,201
103,971Insider9.16%29,736
45,228Insider3.98%12,935
7,388Institution0.65%2,113
7,388Institution0.65%2,113
3,673Institution0.32%1,050

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,388Institution0.65%2,113
3,673Institution0.32%1,050

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
7,388Institution0.65%6,797

FAQ

Who Owns Ampio Pharmaceuticals (AMPE)?
Currently, no data Available
What percentage of Ampio Pharmaceuticals (AMPE) stock is held by institutional investors?
Currently, no data Available
What percentage of Ampio Pharmaceuticals (AMPE) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Ampio Pharmaceuticals (AMPE)?
Michael Macaluso owns the most shares of Ampio Pharmaceuticals (AMPE).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis